Dr. Clemens Schirmer, MD, PhD
Claim this profileGeisinger Medical Center
Studies Stroke
Studies Brain Aneurysm
12 reported clinical trials
18 drugs studied
Affiliated Hospitals
Clinical Trials Clemens Schirmer, MD, PhD is currently running
Intra-arterial Drug Therapy
for Cerebral Vasospasm
The primary objective of the study is to determine the optimal intra-arterial drug treatment regimen for arterial lumen restoration post cerebral vasospasm following aneurysmal subarachnoid hemorrhage. The secondary objective is to evaluate clinical outcome at 90 days post discharge following optimal intra-arterial drug treatment for cerebral vasospasm. We hypothesize that Intra-arterial (IA) infusion of a combination of multiple vasodilators is more efficacious than single agent treatment cerebral vasospasm therapy. All procedures done as a part of this study are standard hospital care procedures done to treat cerebral vasospasm and all drugs to be used are FDA approved.
Recruiting3 awards Phase 43 criteria
Apixaban vs Aspirin
for Stroke Prevention in Atrial Fibrillation After Brain Bleed
Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes as measured by the modified Rankin Scale.
Recruiting1 award Phase 36 criteria
More about Clemens Schirmer, MD, PhD
Clinical Trial Related8 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Clemens Schirmer, MD, PhD has experience with
- EmboTrap® Revascularization Device
- CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter
- Pipeline™ Flex Embolization Device With Shield Technology™
- Intra-arterial Thrombectomy
- Sedation
- General Anesthesia (GA)
Breakdown of trials Clemens Schirmer, MD, PhD has run
Stroke
Brain Aneurysm
Bleeding
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Clemens Schirmer, MD, PhD specialize in?
Clemens Schirmer, MD, PhD focuses on Stroke and Brain Aneurysm. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Clemens Schirmer, MD, PhD currently recruiting for clinical trials?
Yes, Clemens Schirmer, MD, PhD is currently recruiting for 4 clinical trials in Danville Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Clemens Schirmer, MD, PhD has studied deeply?
Yes, Clemens Schirmer, MD, PhD has studied treatments such as EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter, Pipeline™ Flex Embolization Device with Shield Technology™.
What is the best way to schedule an appointment with Clemens Schirmer, MD, PhD?
Apply for one of the trials that Clemens Schirmer, MD, PhD is conducting.
What is the office address of Clemens Schirmer, MD, PhD?
The office of Clemens Schirmer, MD, PhD is located at: Geisinger Medical Center, Danville, Pennsylvania 17822 United States. This is the address for their practice at the Geisinger Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.